(Q37669645)

3 July 2019

review article

1 reference

title

Peripheral metabolic effects of endocannabinoids and cannabinoid receptor blockade (English)

1 reference

3 July 2019

0 references

0 references

0 references

Stefan Engeli

1

1 reference

3 July 2019

language of work or name

1 reference

8 February 2008

1 reference

3 July 2019

published in

Obesity Facts

1 reference

3 July 2019

volume

1

1 reference

3 July 2019

issue

1

1 reference

3 July 2019

page(s)

8-15

1 reference

3 July 2019

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

cites work

1 reference

12 December 2020

Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors

1 reference

12 December 2020

Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses

1 reference

12 December 2020

Leptin-regulated endocannabinoids are involved in maintaining food intake

1 reference

12 December 2020

Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis

1 reference

12 December 2020

Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats

1 reference

12 December 2020

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

1 reference

12 December 2020

Tetrahydrocannabinol and endocannabinoids in feeding and appetite

1 reference

12 December 2020

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

1 reference

12 December 2020

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

1 reference

12 December 2020

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

1 reference

12 December 2020

The cannabinoid system: a role in both the homeostatic and hedonic control of eating?

1 reference

12 December 2020

The molecular logic of endocannabinoid signalling

1 reference

12 December 2020

Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain

1 reference

12 December 2020

Molecular characterization of a phospholipase D generating anandamide and its congeners

1 reference

12 December 2020

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

12 December 2020

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

1 reference

12 December 2020

Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin.

1 reference

12 December 2020

The endocannabinoid system and its therapeutic exploitation

1 reference

12 December 2020

The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin.

1 reference

12 December 2020

Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide

1 reference

12 December 2020

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

1 reference

12 December 2020

Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility

1 reference

12 December 2020

Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

1 reference

12 December 2020

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

12 December 2020

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

1 reference

12 December 2020

Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase.

1 reference

12 December 2020

Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation

1 reference

12 December 2020

PPAR-gamma: a nuclear receptor with affinity for cannabinoids

1 reference

12 December 2020

The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

1 reference

12 December 2020

Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide

1 reference

12 December 2020

Activation of the peripheral endocannabinoid system in human obesity

1 reference

12 December 2020

Identification and functional characterization of brainstem cannabinoid CB2 receptors

1 reference

12 December 2020

The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes

1 reference

12 December 2020

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

1 reference

12 December 2020

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

1 reference

12 December 2020

Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell.

1 reference

12 December 2020

Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit

1 reference

12 December 2020

Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes

1 reference

12 December 2020

Activation of cannabinoid CB1 receptors induces glucose intolerance in rats.

1 reference

12 December 2020

Ghrelin receptors in rat and human nodose ganglia: putative role in regulating CB-1 and MCH receptor abundance

1 reference

12 December 2020

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

1 reference

12 December 2020

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

1 reference

12 December 2020

CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis

1 reference

12 December 2020

Cannabinoid receptor signaling directly inhibits thermogenesis and alters expression of adiponectin and visfatin

1 reference

12 December 2020

The cannabinoid CB1 receptor inverse agonist, rimonabant, modifies body weight and adiponectin function in diet-induced obese rats as a consequence of reduced food intake

1 reference

12 December 2020

Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.

1 reference

12 December 2020

The endocannabinoid system as an emerging target of pharmacotherapy

1 reference

12 December 2020

Central nervous system control of food intake and body weight

1 reference

12 December 2020

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

1 reference

12 December 2020

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

1 reference

12 December 2020

Molecular cloning of a human cannabinoid receptor which is also expressed in testis

1 reference

12 December 2020

Endocannabinoids in adipocytes during differentiation and their role in glucose uptake.

1 reference

12 December 2020

Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta

1 reference

12 December 2020

Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.

1 reference

12 December 2020

Effects of cannabinoid receptors on skeletal muscle oxidative pathways

1 reference

12 December 2020

Human adipose tissue cannabinoid receptor 1 gene expression is not related to fat cell function or adiponectin level

1 reference

12 December 2020

Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury

1 reference

12 December 2020

Identification of endocannabinoids and related compounds in human fat cells

1 reference

12 December 2020

Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase

1 reference

12 December 2020

The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use.

1 reference

12 December 2020

Distribution of type 1 cannabinoid receptor (CB1)-immunoreactive axons in the mouse hypothalamus.

1 reference

12 December 2020

Role of cannabinoid CB2 receptors in glucose homeostasis in rats

1 reference

12 December 2020

Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

1 reference

12 December 2020

[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor

1 reference

12 December 2020

Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats

1 reference

12 December 2020

Mechanisms for the coupling of cannabinoid receptors to intracellular calcium mobilization in rat insulinoma beta-cells

1 reference

12 December 2020

Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity

1 reference

12 December 2020

Adipose tissue macrophages.

1 reference

12 December 2020

The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms

1 reference

12 December 2020

Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats

1 reference

12 December 2020

The endocannabinoid system and gut-brain signalling.

1 reference

12 December 2020

Therapeutic potential of endocannabinoid-hydrolysing enzyme inhibitors.

1 reference

12 December 2020

The pharmacology of the cannabinoid system--a question of efficacy and selectivity

1 reference

12 December 2020

Long term pharmacotherapy for obesity and overweight: updated meta-analysis.

1 reference

12 December 2020

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

12 December 2020

Determination and characterization of a cannabinoid receptor in rat brain

1 reference

12 December 2020

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

12 December 2020

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

12 December 2020

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

12 December 2020

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

1 reference

12 December 2020

cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases

1 reference

12 December 2020

Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock

1 reference

12 December 2020

Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

1 reference

12 December 2020

Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice

1 reference

12 December 2020

Identifiers

DOI

10.1159/000114255

1 reference

3 July 2019

PMC publication ID

6444701

1 reference

3 July 2019

PubMed publication ID

20054157

1 reference

3 July 2019